EE656 A Cost-Utility Analysis of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, a Rare Disease, in Spain

Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.895
https://www.valueinhealthjournal.com/article/S1098-3015(22)03099-6/fulltext
Section Title :
Section Order : 10440
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03099-6&doi=10.1016/j.jval.2022.09.895
HEOR Topics :
Tags :
Regions :